» Articles » PMID: 30298911

Immune Cells in the Tumour: New Routes of Retinoids for Chemoprevention and Chemotherapeutics

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2018 Oct 10
PMID 30298911
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoids, vitamin A and its natural and synthetic analogues have various functions, including being involved in cell proliferation and differentiation and participating in the formation of vertebrate morphology. In addition, they may activate certain tumour suppressor genes that then act as tumour inhibitors. In the past decades, retinoids have been regarded as promising chemotherapeutic and chemopreventive agents; however, their mechanisms are still not fully understood. Immune cells that participate in or are associated with the immune response play vital roles in the initiation and development of many cancers. Interestingly, recent studies have demonstrated that retinoids can also exert various effects on immune cells including macrophages, T cells and dendritic cells in tumour tissues to execute anti-tumour actions, providing new insights into chemoprevention and chemotherapeutics. In this review, we focus on the effects of retinoids on immune cells in the tumour, which may provide new approaches for antineoplastic strategies.

Citing Articles

Cold Physical Plasma-Mediated Fenretinide Prodrug Activation Confers Additive Cytotoxicity in Epithelial Cells.

Ahmadi M, Singer D, Potlitz F, Nasri Z, von Woedtke T, Link A Antioxidants (Basel). 2023; 12(6).

PMID: 37372001 PMC: 10295284. DOI: 10.3390/antiox12061271.


TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.

Fan W, Zhou M, Wang D, Jiang X, Ding H Genet Mol Biol. 2023; 46(2):e20220323.

PMID: 37335919 PMC: 10278923. DOI: 10.1590/1678-4685-GMB-2022-0323.


Z-isomerization of retinoids through combination of monochromatic photoisomerization and metal catalysis.

Kahremany S, Sander C, Tochtrop G, Kubas A, Palczewski K Org Biomol Chem. 2019; 17(35):8125-8139.

PMID: 31455964 PMC: 6739180. DOI: 10.1039/c9ob01645g.


Catalytic synthesis of 9-cis-retinoids: mechanistic insights.

Kahremany S, Kubas A, Tochtrop G, Palczewski K Dalton Trans. 2019; 48(28):10581-10595.

PMID: 31218312 PMC: 7004310. DOI: 10.1039/c9dt02189b.


Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics.

Jiang L, Dong R, Ying M, He Q, Cao J, Yang B Br J Pharmacol. 2018; 175(23):4285-4294.

PMID: 30298911 PMC: 6240126. DOI: 10.1111/bph.14511.

References
1.
Strober W . Vitamin A rewrites the ABCs of oral tolerance. Mucosal Immunol. 2008; 1(2):92-5. DOI: 10.1038/mi.2007.22. View

2.
Zhang R, Li F, Li H, Yu J, Ren X . The clinical significance of memory T cells and its subsets in gastric cancer. Clin Transl Oncol. 2013; 16(3):257-65. DOI: 10.1007/s12094-013-1066-5. View

3.
Ponthan F, Kogner P, Bjellerup P, Klevenvall L, Hassan M . Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat. Br J Cancer. 2001; 85(12):2004-9. PMC: 2364024. DOI: 10.1054/bjoc.2001.2186. View

4.
Spilianakis C, Lee G, Flavell R . Twisting the Th1/Th2 immune response via the retinoid X receptor: lessons from a genetic approach. Eur J Immunol. 2005; 35(12):3400-4. DOI: 10.1002/eji.200535588. View

5.
Uray I, Dmitrovsky E, Brown P . Retinoids and rexinoids in cancer prevention: from laboratory to clinic. Semin Oncol. 2016; 43(1):49-64. PMC: 4789177. DOI: 10.1053/j.seminoncol.2015.09.002. View